LU86414A1 - Formulation pharmaceutique et procede pour proteger des malades contre les effets secondaires du cis-platine - Google Patents

Formulation pharmaceutique et procede pour proteger des malades contre les effets secondaires du cis-platine Download PDF

Info

Publication number
LU86414A1
LU86414A1 LU86414A LU86414A LU86414A1 LU 86414 A1 LU86414 A1 LU 86414A1 LU 86414 A LU86414 A LU 86414A LU 86414 A LU86414 A LU 86414A LU 86414 A1 LU86414 A1 LU 86414A1
Authority
LU
Luxembourg
Prior art keywords
cis
platinum
side effects
gsh
pharmaceutical formulation
Prior art date
Application number
LU86414A
Other languages
English (en)
French (fr)
Inventor
Sergio Tognella
Odoardo Tofanetti
Ennio Cavalletti
Roberto Assereto
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Publication of LU86414A1 publication Critical patent/LU86414A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU86414A 1985-05-06 1986-04-30 Formulation pharmaceutique et procede pour proteger des malades contre les effets secondaires du cis-platine LU86414A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20591/85A IT1200467B (it) 1985-05-06 1985-05-06 Formulazione farmaceutica
IT2059185 1985-05-06

Publications (1)

Publication Number Publication Date
LU86414A1 true LU86414A1 (fr) 1986-09-02

Family

ID=11169266

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86414A LU86414A1 (fr) 1985-05-06 1986-04-30 Formulation pharmaceutique et procede pour proteger des malades contre les effets secondaires du cis-platine

Country Status (11)

Country Link
BE (1) BE904717A (it)
CH (1) CH672988A5 (it)
DE (1) DE3615313A1 (it)
FR (1) FR2581312B1 (it)
GB (1) GB2174905B (it)
HK (1) HK69890A (it)
IT (1) IT1200467B (it)
LU (1) LU86414A1 (it)
NL (1) NL8601157A (it)
SE (1) SE8602060L (it)
SG (1) SG62190G (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01203334A (ja) * 1988-02-08 1989-08-16 Mochida Pharmaceut Co Ltd 白金を含有する薬剤の副作用軽減剤
ES2063521T3 (es) * 1990-08-20 1995-01-01 Gerhard Dr Med Ohlenschlager Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano.
US5925620A (en) * 1990-08-20 1999-07-20 Ohlenschlaeger; Gerhard Therapeutically active mixture of glutathione and anthocyanin compounds
ITMI20052449A1 (it) 2005-12-22 2007-06-23 Cell Therapeutics Europe Srl Nuovi bis-platino complessi ad attivita' antitumorale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3866M (fr) * 1964-07-08 1966-01-24 Rocal Médicament a base de dérivé du pyrocatéchol.
GB1110392A (en) * 1964-09-28 1968-04-18 Yamanouchi Pharma Co Ltd Composition containing glutathione and an amino acid or amino acids, and salts thereof
ATE22532T1 (de) * 1982-03-01 1986-10-15 Efamol Ltd Pharmazeutische zusammensetzung.

Also Published As

Publication number Publication date
IT1200467B (it) 1989-01-18
GB2174905B (en) 1989-09-20
GB8610970D0 (en) 1986-06-11
SE8602060D0 (sv) 1986-05-05
SE8602060L (sv) 1986-11-07
IT8520591A0 (it) 1985-05-06
DE3615313A1 (de) 1986-11-20
BE904717A (nl) 1986-09-01
SG62190G (en) 1990-09-07
HK69890A (en) 1990-09-14
FR2581312A1 (fr) 1986-11-07
CH672988A5 (it) 1990-01-31
GB2174905A (en) 1986-11-19
FR2581312B1 (fr) 1992-05-29
NL8601157A (nl) 1986-12-01

Similar Documents

Publication Publication Date Title
Thomas et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis
CH681692A5 (it)
Ferreira et al. Nitric oxide-dependent vasodilatation by ethanolic extract of Hancornia speciosa via phosphatidyl-inositol 3-kinase
US20170151200A1 (en) Prophylactic or therapeutic agent for idiopathic inflammatory myopathies
EP0673650B1 (fr) Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine
Kim The mechanism of the NLRP3 inflammasome activation and pathogenic implication in the pathogenesis of gout
EP2648704A1 (en) Anti-microbial composition
LU86414A1 (fr) Formulation pharmaceutique et procede pour proteger des malades contre les effets secondaires du cis-platine
Alshora et al. The role of sodium lauryl sulfate on formulation of directly compressed tablets containing simvastatin and aspirin: Effect on drugs dissolution and gastric mucosa
EP0284588B1 (fr) Préparation pharmaceutique à base d'indométacine
Bertsias1BCDEF et al. Review of clinical and toxicological features of acute pesticide poisonings in Crete (Greece) during the period 1991–2001
Weisinger et al. The effect of captopril or enalaprilic acid on the Na appetite of Na‐deplete rats
EP0075523B1 (fr) Nouveaux médicaments à base d'extraits d'algues, et formulations correspondantes
Kraml et al. Gastrointestinal Absorption of Griseofulvin: Levels in the Serum of Human Patients on Prolonged BID Administration of Micronized and Common Griseofulvin
Mahmoud et al. Aqueous garlic extract alleviates liver fibrosis and renal dysfunction in bile-duct-ligated rats
Zeldowicz et al. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa
EP0732918B1 (fr) Solution injectable de fluorure de benzalkonium
FR2485371A1 (fr) Nouvelle composition a usage therapeutique a base de lysine et d'arginine
JP2003528152A (ja) 肝細胞性不全症の処置におけるｓｏｄ模擬体の使用
Gray et al. Studies On the Inhibition of Xanthine Oxidase.
Zhang et al. Impact of Salt Intake and RAAS blockade on lung SARS CoV-2 Host Factors
Ibadi et al. A Study of the effect of Octreotide and N-acetylcysteine on inflammatory and prognostic parameters in severe acute pancreatitis in rats
EP1317922A1 (fr) Preparation antipyretique renfermant du xylitol
JP7244121B2 (ja) 好中球の活性化及び動員の異常調節に関連する疾患の治療方法
FR2528702A1 (fr) Application du n-(diethylaminoethyl) 2-methoxy-5-methylsulfonyl benzamide dans l'inhibition de la tryptophane pyrrolase